Osprey Medical Inc. announced publication of results from the pilot clinical trial of the AVERT system (Contrast Conservation System/CCS). The 21-patient pilot clinical trial, demonstrated that the use of the AVERT System was associated with a highly significant 40% reduction in dye injection compared with standard imaging techniques, whilst maintaining image quality.